Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01551095 · ClinicalTrials.gov registry record · Phase 2
Self-Propelled Percutaneous Endoscopic GastroJejunostomy (PEG-J)
A Phase 2 study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 7
- Enrollment target
NCT01551095: Clinical Trial Phase 2 study, sponsored by Johns Hopkins University.
NCT01551095 is a Phase 2 study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01551095, a Phase 2 study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 7 participants
- Enrollment target
Study Summary
This research is being done to study the safety of an investigational percutaneous endoscopic gastrojejunostomy (PEGJ) tube and whether the addition of a balloon on the end of the J tube prevents it from slipping back into the stomach.
Interventions
- DEVICE PEGJ tube
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2012-01 |
| Est. Completion | 2012-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01551095
The ClinicalTrials.gov registry entry for NCT01551095 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PEGJ tube is the first listed.
NCT01551095 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01551095 about?
NCT01551095 is a clinical study titled "Self-Propelled Percutaneous Endoscopic GastroJejunostomy (PEG-J)". This research is being done to study the safety of an investigational percutaneous endoscopic gastrojejunostomy (PEGJ) tube and whether the addition of a balloon on the end of the J tube prevents it from slipping back into the stomach.
What is the current status of trial NCT01551095?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2012-01. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01551095?
The interventions under investigation include: PEGJ tube (DEVICE).
Who is sponsoring clinical trial NCT01551095?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.